Search

The following topics are under this section: China Market Access for MedTech via Hong Kong and the Greater Bay Area Initiative Don't Panic, Be Cautious, and Together We Can Stop the Coronavirus Epidemic! — Supplementary Charts CytoMed Therapeutics – Pioneer in Advancing Cellular Immunotherapy against Cancer Read on - Opinion editorial on MedTech market access to China, supplementary charts by Professor Lawrence Lau, and Game Changer of the month: CytoMed Therapeutics. [ABSTRACT FROM AUTHOR]

The author discusses the significant evolution of the social and economic condition of Hong Kong, China after the British government returned its sovereignty. He outlines the blooming condition of the territory which motivates artists, investors, and immigrants to relocate in the area. The author also shares his experience in returning back to the territory from California in which he realized the stronger sense of community and emphasis of returning to life's basics.

China Telecom and China Unicom Hong Kong may be set to collaborate on a content delivery network (CDN) company in a bid to speed up internet access for Chinese users, according to local reports. [ABSTRACT FROM AUTHOR]

JW Therapeutics has filed the paperwork for a Hong Kong IPO. The Juno Therapeutics-WuXi AppTech joint venture is seeking money to advance a cell therapy pipeline led by anti-CD19 CAR-T JWCAR029. [ABSTRACT FROM AUTHOR]